Krishnendu Gupta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Krishnendu Gupta has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Pisake Lumbiganon
Department of Obstetrics and Gynecology, Faculty of Medicine Khon Kaen University Khon Kaen Thailand
3 shared publicationsRohana Haththotuwa
College of Obstetricians and Gynaecoloists Colombo Sri Lanka
3 shared publicationsJohn Tait
Department of Obstetrics and Gynaecology The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Wellington New Zealand
2 shared publications- U. D. P. Ratnasiri
Department of Obstetrics and Gynaecology Sri Lanka College of Obstetricians and Gynaecologists Colombo Sri Lanka
2 shared publications Ai Ling Tan
Department of Gynaecology Ascot Hospital Remuera New Zealand
1 shared publicationAlyssa L. Olson
School of Global Health, Faculty of Medicine Chulalongkorn University Bangkok Thailand
1 shared publication
Latest Publications
- 26 July 2025
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 51 (8) , e70004
The AOFOG declaration on violence against women: A regional call to action for Asia and Oceania
Violence against women remains a severe human rights violation and public health challenge across Asia and Oceania, with significant variations in prevalence and response capacity among countries. Despite global frameworks such as the Convention on the Elimination of All Forms of Discrimination Against Women and regional initiatives like the ASEAN Declaration on the Elimination of Violence Against Women and Violence Against Children, implementation gaps hinder effective protection. The Asia‐Oceania Federation of Obstetrics and Gynaecology (AOFOG) Declaration on Violence Against Women: A Commitment to Action and Change reinforces key commitments across 10 action areas, including recognizing violence against women as a critical issue, advancing international agreements, strengthening regional cooperation, mobilizing stakeholders, empowering healthcare professionals, enhancing comprehensive services, promoting public education, improving healthcare training, supporting research and data collection, and preparing for crisis responses such as pandemics. Emphasizing evidence‐based policymaking and regional collaboration, the Declaration establishes a roadmap for accountability through robust monitoring and evaluation. By uniting stakeholders across sectors, AOFOG aims to eliminate VAW and foster environments where women's rights, safety, and dignity are universally upheld. This Declaration was officially presented at the 28th AOFOG Congress held in Busan, Korea, on May 18, 2024.
- 26 July 2025
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 51 (8) , e70004
The AOFOG declaration on violence against women: A regional call to action for Asia and Oceania
Violence against women remains a severe human rights violation and public health challenge across Asia and Oceania, with significant variations in prevalence and response capacity among countries. Despite global frameworks such as the Convention on the Elimination of All Forms of Discrimination Against Women and regional initiatives like the ASEAN Declaration on the Elimination of Violence Against Women and Violence Against Children, implementation gaps hinder effective protection. The Asia‐Oceania Federation of Obstetrics and Gynaecology (AOFOG) Declaration on Violence Against Women: A Commitment to Action and Change reinforces key commitments across 10 action areas, including recognizing violence against women as a critical issue, advancing international agreements, strengthening regional cooperation, mobilizing stakeholders, empowering healthcare professionals, enhancing comprehensive services, promoting public education, improving healthcare training, supporting research and data collection, and preparing for crisis responses such as pandemics. Emphasizing evidence‐based policymaking and regional collaboration, the Declaration establishes a roadmap for accountability through robust monitoring and evaluation. By uniting stakeholders across sectors, AOFOG aims to eliminate VAW and foster environments where women's rights, safety, and dignity are universally upheld. This Declaration was officially presented at the 28th AOFOG Congress held in Busan, Korea, on May 18, 2024.
- 10 April 2025
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 51 (4) , e16288
AOFOG recommendation on postpartum hemorrhage care bundle approach to improve adherence to the WHO guidelines
Global maternal mortality estimates 287 000 deaths in 2020. Obstetric hemorrhage is a leading cause contributing to 27% of all maternal deaths. The Asia Oceania Federation of Obstetrics and Gynaecology (AOFOG) recommendation aims to reduce the postpartum hemorrhagic deaths with the use of a care bundle approach published by the World Health Organization in the Asia Oceania region. The care bundle approach has been shown to reduce the risk of the primary outcome, a composite of severe postpartum hemorrhage, laparotomy for bleeding, or death from bleeding, compared to usual care among patients having vaginal delivery. In a large, international, parallel cluster‐randomized trial, the E‐MOTIVE trial. The AOFOG recommends the care bundle approach on postpartum hemorrhage to improve adherence to the World Health Organization guidelines in achieving reduction of morbidity and mortality in maternal death with postpartum hemorrhage.
- 10 April 2025
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 51 (4) , e16288
AOFOG recommendation on postpartum hemorrhage care bundle approach to improve adherence to the WHO guidelines
Global maternal mortality estimates 287 000 deaths in 2020. Obstetric hemorrhage is a leading cause contributing to 27% of all maternal deaths. The Asia Oceania Federation of Obstetrics and Gynaecology (AOFOG) recommendation aims to reduce the postpartum hemorrhagic deaths with the use of a care bundle approach published by the World Health Organization in the Asia Oceania region. The care bundle approach has been shown to reduce the risk of the primary outcome, a composite of severe postpartum hemorrhage, laparotomy for bleeding, or death from bleeding, compared to usual care among patients having vaginal delivery. In a large, international, parallel cluster‐randomized trial, the E‐MOTIVE trial. The AOFOG recommends the care bundle approach on postpartum hemorrhage to improve adherence to the World Health Organization guidelines in achieving reduction of morbidity and mortality in maternal death with postpartum hemorrhage.
- 29 October 2024
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 50 (S1) , 55-64
Navigating the landscape of cervical cancer in India: Epidemiology, prevention, current status, and emerging solutions
Cervical cancer poses a significant health burden for women worldwide, particularly in India. Despite global progress, India's mortality rate, with 79 906 deaths, remains disproportionately high at approximately 11.2 per 100 000 women compared to the global average of 7.1 per 100 000 women. India's NPCDCS and other initiatives focus on VIA screening for women aged 30–65. The National Health Policy 2017 emphasizes primary healthcare enhancement, allocating two‐thirds of the budget. Ayushman Bharat promotes universal health coverage, including Health and Wellness Centers and PM‐JAY. Initiatives like Ayushman Bharat and the National Cancer Grid offer hope for improved cancer care. Leveraging technology, strengthening infrastructure, integrating services, promoting awareness, and enhancing HPV vaccination are crucial. By addressing barriers, improving access, and fostering collaboration, the cervical cancer burden can be reduced, ensuring better health outcomes for women nationwide.
- 29 October 2024
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 50 (S1) , 55-64
Navigating the landscape of cervical cancer in India: Epidemiology, prevention, current status, and emerging solutions
Cervical cancer poses a significant health burden for women worldwide, particularly in India. Despite global progress, India's mortality rate, with 79 906 deaths, remains disproportionately high at approximately 11.2 per 100 000 women compared to the global average of 7.1 per 100 000 women. India's NPCDCS and other initiatives focus on VIA screening for women aged 30–65. The National Health Policy 2017 emphasizes primary healthcare enhancement, allocating two‐thirds of the budget. Ayushman Bharat promotes universal health coverage, including Health and Wellness Centers and PM‐JAY. Initiatives like Ayushman Bharat and the National Cancer Grid offer hope for improved cancer care. Leveraging technology, strengthening infrastructure, integrating services, promoting awareness, and enhancing HPV vaccination are crucial. By addressing barriers, improving access, and fostering collaboration, the cervical cancer burden can be reduced, ensuring better health outcomes for women nationwide.
- Open Access
- 29 October 2024
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 50 (S1) , 95-102
The AOFOG recommendations on human papillomavirus vaccination in the Asia‐Pacific region
Cervical cancer remains a disease burden in Asia. The Asia and Oceania Federation of Obstetrics and Gynecology envisages a need to produce a set of recommendations on the implementation of human papilloma virus vaccination program for both lower‐middle‐income countries (LMICs) and high‐income countries (HICs), with an attempt to harmonize the practices yet allow flexibility to cater for different cultures, religions, needs and background of individual countries/cities. International guidelines and literature were sought, and recommendations were made in seven selected areas, including (i) the target groups for vaccination, (ii) the doses of vaccination including the use of single‐dose vaccination, (iii) the types of vaccines, (iv) suggestions for special populations including those with previous HPV infection, human immunodeficiency virus carriers, and lesbian, gay, bisexual, transgender, questioning/queer group, (v) inter‐changeability and the need of revaccination/booster, (vi) novel technologies and vaccines, and (vii) public education.
- 29 October 2024
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 50 (S1) , 95-102
Open AccessThe AOFOG recommendations on human papillomavirus vaccination in the Asia‐Pacific region
Cervical cancer remains a disease burden in Asia. The Asia and Oceania Federation of Obstetrics and Gynecology envisages a need to produce a set of recommendations on the implementation of human papilloma virus vaccination program for both lower‐middle‐income countries (LMICs) and high‐income countries (HICs), with an attempt to harmonize the practices yet allow flexibility to cater for different cultures, religions, needs and background of individual countries/cities. International guidelines and literature were sought, and recommendations were made in seven selected areas, including (i) the target groups for vaccination, (ii) the doses of vaccination including the use of single‐dose vaccination, (iii) the types of vaccines, (iv) suggestions for special populations including those with previous HPV infection, human immunodeficiency virus carriers, and lesbian, gay, bisexual, transgender, questioning/queer group, (v) inter‐changeability and the need of revaccination/booster, (vi) novel technologies and vaccines, and (vii) public education.
- 29 October 2024
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 50 (S1) , 18
Message for the 50th Anniversary Special Issue of the Journal of Obstetrics & Gynaecology Research (JOGR)
- 29 October 2024
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 50 (S1) , 18
Message for the 50th Anniversary Special Issue of the Journal of Obstetrics & Gynaecology Research (JOGR)
- 15 February 2024
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 74 (1) , 22-26
Impact of Climate Change, Environmental Toxins and Pollution on the AOFOG region: What can OBGYNs do?
Climate change is occurring rapidly, and this crisis should now be recognized as a “global emergency”. It is one of the major global health threats brought about by global warming, resulting from human activity due in large part to increasing levels of greenhouse gases. The ongoing climate crisis poses significant risks to women, pregnant mothers, unborn fetuses and offspring, who were exposed in-utero to climate stressors, especially those in marginalized communities where effects are magnified. A focus on education, research, and advocacy in responding to changing health consequences and global awareness are key to educating our professional healthcare providers, patients, the lay public, key personnel in the government and other leaders, and by making the changes necessary to address this crisis. Building on the pillars that FIGO has identified (advocacy, research interpretation, capacity building, and education), and following the footsteps of the FIGO Committee on “Climate Change and Toxic Environmental Exposures”, the baby steps yet focussed efforts taken by AOFOG through its recently formed “Climate Change & Pollution Working Group” will be highlighted in this review article. After all, investing in the health of women is investing in the health of current and future generations, and we, as healthcare providers along with health professional organizations should be in the forefront of environmental health advocacy to save the present generation and future generations through engagement as public opinion leaders.
- 15 February 2024
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 74 (1) , 22-26
Impact of Climate Change, Environmental Toxins and Pollution on the AOFOG region: What can OBGYNs do?
Climate change is occurring rapidly, and this crisis should now be recognized as a “global emergency”. It is one of the major global health threats brought about by global warming, resulting from human activity due in large part to increasing levels of greenhouse gases. The ongoing climate crisis poses significant risks to women, pregnant mothers, unborn fetuses and offspring, who were exposed in-utero to climate stressors, especially those in marginalized communities where effects are magnified. A focus on education, research, and advocacy in responding to changing health consequences and global awareness are key to educating our professional healthcare providers, patients, the lay public, key personnel in the government and other leaders, and by making the changes necessary to address this crisis. Building on the pillars that FIGO has identified (advocacy, research interpretation, capacity building, and education), and following the footsteps of the FIGO Committee on “Climate Change and Toxic Environmental Exposures”, the baby steps yet focussed efforts taken by AOFOG through its recently formed “Climate Change & Pollution Working Group” will be highlighted in this review article. After all, investing in the health of women is investing in the health of current and future generations, and we, as healthcare providers along with health professional organizations should be in the forefront of environmental health advocacy to save the present generation and future generations through engagement as public opinion leaders.